Cargando…
Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation
New technologies such as genomics present opportunities to deliver precision medicine, including in the diagnosis of rare kidney disorders. Simultaneously, social media platforms such as Twitter can provide rapid and wide-reaching information dissemination in health care and science. We present 2 ca...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380393/ https://www.ncbi.nlm.nih.gov/pubmed/32734212 http://dx.doi.org/10.1016/j.xkme.2019.06.006 |
_version_ | 1783562845304127488 |
---|---|
author | Mallett, Andrew J. Quinlan, Catherine Patel, Chirag Fowles, Lindsay Crawford, Joanna Gattas, Michael Baer, Richard Bennetts, Bruce Ho, Gladys Holman, Katherine Simons, Cas |
author_facet | Mallett, Andrew J. Quinlan, Catherine Patel, Chirag Fowles, Lindsay Crawford, Joanna Gattas, Michael Baer, Richard Bennetts, Bruce Ho, Gladys Holman, Katherine Simons, Cas |
author_sort | Mallett, Andrew J. |
collection | PubMed |
description | New technologies such as genomics present opportunities to deliver precision medicine, including in the diagnosis of rare kidney disorders. Simultaneously, social media platforms such as Twitter can provide rapid and wide-reaching information dissemination in health care and science. We present 2 cases in which the reporting of a novel genetic cause for human kidney disease was communicated through Twitter and then subsequently noted by treating clinicians, thereby resulting in rapid clinical diagnostic translation. In 1 family, this involved the reporting of heterozygous variants in GREB1L relating to autosomal dominant unilateral or bilateral renal agenesis, and in the other family, this involved biallelic variants in CLDN10 relating to autosomal recessive hypokalemic renal tubular phenotypes. The times from Twitter notification to clinical diagnostic genetic report for these families were 111 and 200 days, respectively. Although caution is required, these cases show that social media platforms can contribute to rapid and accessible academic communication that may benefit clinicians, genomics-based researchers, and patients and families affected by rare kidney diseases. |
format | Online Article Text |
id | pubmed-7380393 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-73803932020-07-29 Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation Mallett, Andrew J. Quinlan, Catherine Patel, Chirag Fowles, Lindsay Crawford, Joanna Gattas, Michael Baer, Richard Bennetts, Bruce Ho, Gladys Holman, Katherine Simons, Cas Kidney Med Case Report New technologies such as genomics present opportunities to deliver precision medicine, including in the diagnosis of rare kidney disorders. Simultaneously, social media platforms such as Twitter can provide rapid and wide-reaching information dissemination in health care and science. We present 2 cases in which the reporting of a novel genetic cause for human kidney disease was communicated through Twitter and then subsequently noted by treating clinicians, thereby resulting in rapid clinical diagnostic translation. In 1 family, this involved the reporting of heterozygous variants in GREB1L relating to autosomal dominant unilateral or bilateral renal agenesis, and in the other family, this involved biallelic variants in CLDN10 relating to autosomal recessive hypokalemic renal tubular phenotypes. The times from Twitter notification to clinical diagnostic genetic report for these families were 111 and 200 days, respectively. Although caution is required, these cases show that social media platforms can contribute to rapid and accessible academic communication that may benefit clinicians, genomics-based researchers, and patients and families affected by rare kidney diseases. Elsevier 2019-08-14 /pmc/articles/PMC7380393/ /pubmed/32734212 http://dx.doi.org/10.1016/j.xkme.2019.06.006 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Mallett, Andrew J. Quinlan, Catherine Patel, Chirag Fowles, Lindsay Crawford, Joanna Gattas, Michael Baer, Richard Bennetts, Bruce Ho, Gladys Holman, Katherine Simons, Cas Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation |
title | Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation |
title_full | Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation |
title_fullStr | Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation |
title_full_unstemmed | Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation |
title_short | Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation |
title_sort | precision medicine diagnostics for rare kidney disease: twitter as a tool in clinical genomic translation |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380393/ https://www.ncbi.nlm.nih.gov/pubmed/32734212 http://dx.doi.org/10.1016/j.xkme.2019.06.006 |
work_keys_str_mv | AT mallettandrewj precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT quinlancatherine precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT patelchirag precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT fowleslindsay precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT crawfordjoanna precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT gattasmichael precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT baerrichard precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT bennettsbruce precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT hogladys precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT holmankatherine precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation AT simonscas precisionmedicinediagnosticsforrarekidneydiseasetwitterasatoolinclinicalgenomictranslation |